← All peptides
Cognitive & Nootropic
Research Chemical

Emideltide

Also known as: Emideltide

A research peptide related to delta sleep-inducing peptide (DSIP) chemistry, marketed for its potential effects on sleep regulation and stress modulation. Human data are minimal and it remains an investigational research compound.

Last updated

Mechanism of Action

Emideltide is described as a delta sleep-inducing peptide analog that is thought to influence the neuromodulatory systems governing slow-wave sleep. Like DSIP, it is proposed to interact with central pathways that promote delta-frequency EEG activity and to modulate the hypothalamic-pituitary-adrenal stress axis. The precise receptor targets remain poorly characterized, and its activity is inferred largely from the broader DSIP literature. Reported effects center on sleep architecture, stress resilience and neuroendocrine balance.

Half-life
Short; on the order of minutes, consistent with related sleep peptides
Administration Routes
subcutaneous
Research Status
Research Chemical

Reported Benefits

  • Studied for promotion of deep, slow-wave sleep
  • May support stress-axis modulation
  • Investigated for circadian and sleep-quality effects
  • Possible neuroprotective and adaptogenic activity in line with DSIP research
  • Explored as a non-sedative sleep-support peptide

Potential Side Effects

  • Daytime grogginess or drowsiness
  • Headache
  • Possible changes in mood
  • Injection-site irritation

Common Dosing

No standardized dosing exists; related DSIP-type peptides are studied in microgram-to-low-milligram amounts administered before sleep. Provided for research-use-only context and not as personal medical advice.

The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.

Contraindications

  • Pregnancy and breastfeeding due to absent safety data
  • Known hypersensitivity to the peptide
  • Use with other sedatives without caution
  • Delta sleep-inducing peptide (DSIP): a still unresolved riddle

    2006

    View
  • Delta sleep-inducing peptide in normal humans and in patients with sleep apnea and narcolepsy

    1995

    View
  • Delta sleep-inducing peptide

    2001

    View
  • Delta sleep-inducing peptide and Deltaran: potential approaches to antistress protection

    2008

    View

It is marketed as a delta sleep-inducing peptide (DSIP)-type compound studied for its potential effects on slow-wave sleep and stress regulation.

No. Human data are minimal and most inferences come from the broader DSIP research literature, so it remains an investigational research compound.

PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.